Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNUH-CD19-CAR-T in Refractory Childhood-Onset Systemic Lupus Erythematosus
NCT07855302Phase 1Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of SNUH-CD19-CAR-T in systemic lupus erythematosus (SLE), sponsored by Seoul National University Hospital. Primary endpoint: Lupus Low Disease Activity State at 1 year. Started Sep 2026; status: recruiting.
02
Drugs
SNUH-CD19-CAR-T
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT07855302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07855302.